Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Greenfield Global Plans for New European Mfg. HQ | Contract Pharma

What are you searching for?

Sign in
Breaking News

Greenfield Global Plans for New European Mfg. HQ

40,900 sq ft manufacturing facility in Portlaoise will be constructed in the IDA Ireland Business and Technology Park and is expected to be operational in 2020

By: Betsy Louda

, Contract Pharma

Greenfield Global Inc has announced plans to establish a new EU manufacturing headquarters in Portlaoise, Ireland.


The new 40,900 square feet manufacturing facility in Portlaoise will be constructed in the IDA Ireland Business and Technology Park and is expected to be operational in Q2, 2020. The project is supported by the Irish Government through IDA and is expected to create 75 high-quality jobs over the next five years.

“Greenfield is an ambitious company that understands the strength of diversification, be it our products, the markets we serve, or in our operations and supply chain capacity,” said Howard Field, Greenfield president and chief executive officer. “Our commitment to building a world-class GMP manufacturing facility in Portlaoise is our first foray into manufacturing outside of North America. This new facility will ensure we can meet the increasing demand from our life science customers throughout Europe and the region.”

Greenfield, which has its headquarters in Toronto, Canada, has operations in 12 locations across North America. The company’s extensive portfolio of products is trusted by hundreds of customers in pharmaceutical, nutraceutical, life science, personal care, and food, flavor and fragrance markets in over 50 countries.

“Our focus is on improving quality and reliability for our customers,” said Greenfield’s Ken Finegan, managing director, Ireland. “By adding this manufacturing facility, Greenfield’s European life sciences customers will get the certainty they want and need. We will be able to offer them a local source of their critical raw materials to avoid disruption in their supply chain so that they can continue to scale and grow. Sold under the Pharmco brand, these raw materials will initially range from high-purity ethanol blends and solvents, to GMP buffer solutions such as sodium hydroxide and ethanol with water for injection, made in varying concentrations.”
 

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics